Cipla Limited
NSE: CIPLA BSE: CIPLA
Prev Close
1515.2
Open Price
1525
Volume
570,127
Today Low / High
1505 / 1525
52 WK Low / High
1317.25 / 1702.05
Range
1,436 - 1,587
Prev Close
1515.45
Open Price
1529.3
Volume
39,503
Today Low / High
1504.35 / 1529.3
52 WK Low / High
1310.05 / 1702
Range
1,436 - 1,587
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 1511.1 (target range: 1,436 - 1,587), reflecting a change of -4.1 (-0.27059%). On the BSE, it is listed at 1511.5 (target range: 1,436 - 1,587), showing a change of -3.95 (-0.26065%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
Cipla Limited Graph
Cipla Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Cipla Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1,511.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 1,511.50 | 1,526.62 | 1,373.95 - 1,679.28 |
| 1,541.73 | 1,233.38 - 1,850.08 | ||
| 1,556.85 | 1,089.79 - 2,023.90 | ||
| Bearish Scenario | 1,511.50 | 1,496.39 | 1,346.75 - 1,646.02 |
| 1,481.27 | 1,185.02 - 1,777.52 | ||
| 1,466.16 | 1,026.31 - 1,906.00 |
Overview of Cipla Limited
ISIN
INE059A01026
Industry
Drug Manufacturers - General
Vol.Avg
1,635,404
Market Cap
1,227,093,421,740
Last Dividend
13
Official Website
IPO Date
1996-01-01
DCF Diff
-1,547.88
DCF
3,063
Financial Ratios Every Investor Needs
Stock Dividend of CIPLA
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-08-02 | August 02, 24 | 13 | 13 | 2024-08-02 | 2024-09-19 | |
| 2023-07-21 | July 21, 23 | 8.5 | 8.5 | 2023-07-21 | 2023-09-09 | |
| 2022-08-08 | August 08, 22 | 5 | 5 | 2022-08-10 | 2022-09-25 | |
| 2021-08-09 | August 09, 21 | 5 | 5 | 2021-08-10 | 2021-09-24 | |
| 2020-03-19 | March 19, 20 | 1 | 1 | 2020-03-20 | 2020-04-11 | 2020-03-12 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 25,446.63 Cr | 9,043.95 Cr | 16,402.68 Cr | 0.6446 | 430.46 Cr | 1,058.99 Cr | 10,570.99 Cr | 4,121.55 Cr | 51.05 | 6,719.51 Cr | 0.1620 |
| 2023-03-31 | 22,473.18 Cr | 8,960.63 Cr | 13,512.55 Cr | 0.6013 | 385.39 Cr | 928.14 Cr | 4,017.87 Cr | 2,801.91 Cr | 34.72 | 5,152.10 Cr | 0.1247 |
| 2022-03-31 | 21,623.36 Cr | 9,229.72 Cr | 12,393.64 Cr | 0.5732 | 265.68 Cr | 811.97 Cr | 3,570.43 Cr | 2,516.75 Cr | 31.20 | 4,588.20 Cr | 0.1164 |
| 2021-03-31 | 18,988.52 Cr | 8,020.38 Cr | 10,968.14 Cr | 0.5776 | 132.73 Cr | 705.19 Cr | 3,250.74 Cr | 2,404.87 Cr | 29.82 | 4,436.35 Cr | 0.1266 |
| 2020-03-31 | 16,694.85 Cr | 6,609.38 Cr | 10,085.47 Cr | 0.6041 | 354.52 Cr | 781.92 Cr | 2,119.98 Cr | 1,546.52 Cr | 19.19 | 3,465.05 Cr | 0.0926 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 640.07 Cr | 32,717.82 Cr | 5,915.49 Cr | 26,706.4300 Cr | 559.41 Cr | -80.66 Cr | 5,237.95 Cr | 6,171.11 Cr | 135.42 Cr | 58.85 Cr | -1,050.56 Cr | 5,245.7700 Cr |
| 2023-03-31 | 627.63 Cr | 29,463.28 Cr | 5,749.74 Cr | 23,407.7800 Cr | 803.12 Cr | 175.49 Cr | 5,156.43 Cr | 5,679.95 Cr | 46.37 Cr | 50.15 Cr | -4,963.59 Cr | 5,109.6700 Cr |
| 2022-03-31 | 677.74 Cr | 27,101.12 Cr | 5,983.74 Cr | 20,841.6900 Cr | 1,055.78 Cr | 378.04 Cr | 5,350.24 Cr | 5,701.47 Cr | 0.00 Cr | 51.46 Cr | -3,275.15 Cr | 4,913.2100 Cr |
| 2021-03-31 | 793.29 Cr | 25,151.89 Cr | 6,566.30 Cr | 18,326.5300 Cr | 2,014.41 Cr | 1,221.12 Cr | 4,669.18 Cr | 5,644.28 Cr | 12.16 Cr | 63.61 Cr | -242.97 Cr | 4,591.5500 Cr |
| 2020-03-31 | 742.38 Cr | 23,662.56 Cr | 7,605.28 Cr | 15,763.0000 Cr | 3,089.20 Cr | 2,346.82 Cr | 4,377.60 Cr | 5,673.35 Cr | 16.75 Cr | 67.48 Cr | -562.02 Cr | 4,393.1400 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | 4,133.9100 Cr | -2,988.0300 Cr | -1,200.4300 Cr | 2,784.6100 Cr | -48.9900 Cr | 512.3400 Cr | -1,098.2500 Cr | 4,121.5500 Cr | -300.4600 Cr | -686.1700 Cr | -61.8600 Cr |
| 2023-03-31 | 3,237.6500 Cr | -2,388.5100 Cr | -958.2900 Cr | 2,054.7600 Cr | -96.7800 Cr | 561.3300 Cr | -840.5300 Cr | 4,220.7700 Cr | -351.9000 Cr | -403.5000 Cr | 110.7700 Cr |
| 2022-03-31 | 3,325.9000 Cr | -1,871.8800 Cr | -1,599.7900 Cr | 2,624.7500 Cr | -132.3200 Cr | 658.1100 Cr | -701.1500 Cr | 3,675.3900 Cr | -1,133.3100 Cr | -403.3500 Cr | -621.1100 Cr |
| 2021-03-31 | 3,755.2000 Cr | -2,387.1800 Cr | -1,239.5100 Cr | 2,936.2800 Cr | 48.0500 Cr | 793.2900 Cr | -629.6600 Cr | 3,290.0600 Cr | -993.1300 Cr | 0.0000 Cr | -254.3200 Cr |
| 2020-03-31 | 3,068.4500 Cr | 104.0400 Cr | -2,948.8200 Cr | 2,068.4400 Cr | 234.0200 Cr | 742.3800 Cr | -572.7700 Cr | 2,178.1800 Cr | -1,811.9400 Cr | -564.2600 Cr | -331.5500 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | 6,961.60 Cr | 2,264.08 Cr | 4,697.52 Cr | 0.6748 | 1,709.12 Cr | 1,570.51 Cr | 19.45 | 2,210.53 Cr | 0.2256 |
| 2024-09-30 | 7,051.02 Cr | 3,762.63 Cr | 3,288.39 Cr | 0.4664 | 1,613.85 Cr | 1,302.53 Cr | 16.13 | 2,076.20 Cr | 0.1847 |
| 2024-06-30 | 6,624.86 Cr | 3,633.79 Cr | 2,991.07 Cr | 0.4515 | 1,469.12 Cr | 1,177.64 Cr | 14.58 | 1,875.99 Cr | 0.1778 |
| 2024-03-31 | 6,163.24 Cr | 2,822.93 Cr | 3,340.31 Cr | 0.5420 | 1,027.52 Cr | 939.04 Cr | 11.63 | 1,565.19 Cr | 0.1524 |
| 2023-12-31 | 6,505.66 Cr | 2,219.53 Cr | 4,286.13 Cr | 0.6588 | 1,514.10 Cr | 1,055.90 Cr | 13.08 | 1,737.34 Cr | 0.1623 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 797.80 Cr | 7,910.40 Cr | 8,708.20 Cr | 0.00 Cr | 5,572.86 Cr | 20,945.21 Cr | 6,216.58 Cr | 34,655.28 Cr | 6,199.50 Cr |
| 2024-06-30 | -8,146.03 Cr | 15,941.90 Cr | 7,795.87 Cr | 0.00 Cr | 0.00 Cr | 7,795.87 Cr | 0.00 Cr | 0.00 Cr | -26,802.33 Cr |
| 2024-03-31 | 640.07 Cr | 7,138.93 Cr | 7,779.00 Cr | 4,770.66 Cr | 5,237.95 Cr | 19,441.41 Cr | 6,171.11 Cr | 32,717.82 Cr | 5,915.49 Cr |
| 2023-12-31 | -4,890.69 Cr | 9,781.38 Cr | 4,890.69 Cr | 0.00 Cr | 0.00 Cr | 4,890.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-09-30 | 799.84 Cr | 6,374.81 Cr | 7,174.65 Cr | 0.00 Cr | 5,470.12 Cr | 19,007.47 Cr | 5,609.94 Cr | 31,377.09 Cr | 6,281.93 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-06-30 | 1,177.64 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 939.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | 1,055.90 Cr | 466.86 Cr | 0.00 Cr | 0.00 Cr | 466.86 Cr | 1,646.77 Cr | 1,179.91 Cr | 0.00 Cr | 466.86 Cr |
| 2023-09-30 | 1,130.91 Cr | 580.08 Cr | 0.00 Cr | 0.00 Cr | 580.08 Cr | 1,179.91 Cr | 599.83 Cr | 0.00 Cr | 580.08 Cr |
| 2023-06-30 | 995.70 Cr | 478.42 Cr | 0.00 Cr | 0.00 Cr | 478.42 Cr | 1,119.70 Cr | 641.28 Cr | 0.00 Cr | 478.42 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2006-04-24 | April 24, 06 | 5:2 |
| 2004-05-11 | May 11, 04 | 5:1 |
| 1999-10-21 | October 21, 99 | 3:1 |
| 1999-10-18 | October 18, 99 | 3:1 |
Similar Stocks: Drug Manufacturers - General
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Cipla Limited | CIPLA | ₹1,511.10 | ₹1,220,390,199,810.00 | ₹570,127.00 |
| Abbott India Limited | ABBOTINDIA | ₹30,915.00 | ₹656,922,171,330.00 | ₹7,917.00 |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO | ₹2,815.40 | ₹476,945,765,016.00 | ₹85,191.00 |
| Gland Pharma Limited | GLAND | ₹1,464.40 | ₹241,269,301,448.00 | ₹333,283.00 |
| Pfizer Limited | PFIZER | ₹4,191.40 | ₹191,747,043,905.00 | ₹21,385.00 |
| Sanofi India Limited | SANOFI | ₹6,306.50 | ₹145,238,695,000.00 | ₹21,446.00 |
| Marksans Pharma Limited | MARKSANS | ₹214.13 | ₹97,035,955,929.00 | ₹626,692.00 |
Key Executives
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born: 1976
Gender: male
Year Born: 1971
Gender: Not Specified
Year Born: 1965
Gender: female
Year Born:
Gender: female
Year Born:
Gender: female
Year Born:
FAQs about Cipla Limited
The CEO is Mr. Umang Vohra B.E., M.B.A..
The current price is ₹1,519.40.
The range is ₹1317.25-1702.05.
The market capitalization is ₹122,709.34 crores.
The dividend yield is 0.86%.
The P/E ratio is 24.59.
The company operates in the Healthcare sector.
Overview of Cipla Limited (ISIN: INE059A01026) is a leading Drug Manufacturers - General in India. With a market capitalization of ₹122,709.34 crores and an average daily volume of 1,635,404 shares, it operates in the Drug Manufacturers - General. The company last declared a dividend of ₹13.